Catherine Harper-Wynne Selected Research

Catherine Harper-Wynne Research Topics

7	Breast Neoplasms (Breast Cancer) 12/2021 - 07/2002
4	Neoplasms (Cancer) 01/2022 - 07/2015
1	COVID-19 breakthrough infections 01/2022
1	COVID-19 01/2022
1	Breakthrough Infections 01/2022
1	Malignant Pleural Effusion 11/2018
1	Triple Negative Breast Neoplasms 01/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2004
1	Bone Resorption 07/2002
1	Breast Diseases (Breast Disease) 07/2002

4	Aromatase InhibitorsIBA 12/2021 - 07/2002
2	Estrogen ReceptorsIBA 11/2019 - 07/2002
2	Hormones (Hormone)IBA 11/2019 - 04/2008
2	Messenger RNA (mRNA)IBA 01/2018 - 07/2015
2	Biomarkers (Surrogate Marker)IBA 07/2015 - 04/2008
2	Estrogens (Estrogen)FDA Link 04/2008 - 07/2002
1	VaccinesIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	palbociclibIBA 12/2021
1	human ERBB2 proteinIBA 12/2021
1	Epidermal Growth Factor (EGF)IBA 04/2020
1	Fulvestrant (Faslodex)FDA Link 11/2019
1	vistusertibIBA 11/2019
1	Everolimus FDA Link 11/2019
1	Mechanistic Target of Rapamycin Complex 1IBA 11/2019
1	Mechanistic Target of Rapamycin Complex 2IBA 11/2019
1	PlatinumIBA 01/2018
1	Carboplatin (JM8)FDA LinkGeneric 01/2018
1	Trinitrotoluene (TNT)IBA 01/2018
1	Lapatinib (GW572016)FDA Link 07/2015
1	taxaneIBA 10/2010
1	Taxoids (Taxanes)IBA 10/2010
1	AnthracyclinesIBA 10/2010
1	Docetaxel (Taxotere)FDA Link 03/2004
1	EnzymesIBA 07/2002
1	Letrozole (Femara)FDA LinkGeneric 07/2002
1	AndrogensIBA 07/2002
1	Aromatase (CYP19)IBA 07/2002
1	collagen type I trimeric cross-linked peptideIBA 07/2002